In three studies published in Nature today, Australian researchers have made advances in our understanding of how genetic differences between people influence disease. The team from the Garvan Institute of Medical Research, ...
Oct 28, 2026
0
27
Researchers at City of Hope have uncovered an immune pathway that may contribute to radiation-related lung damage and have identified a potential strategy to block it. Published in Nature Communications, the insights from ...
Oct 20, 2026
0
27
The reliable assessment of metabolic dysfunction-associated steatotic liver disease (MASLD) is crucial for determining the stage of the disease, initiating appropriate treatments and monitoring the course of therapy. To date, ...
Nov 1, 2026
0
27
B cells, a type of white blood cell, protect our bodies by producing antibodies that recognize and bind to invaders like bacteria and viruses. After an infection, B cells undergo rapid mutations in the genes that encode antibodies. ...
Nov 2, 2026
0
27
Results from a Phase I clinical trial led by The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC—James) show a possible way to improve therapy ...
Oct 13, 2026
0
27
Retatrutide, a next-generation GLP-1 weight-loss drug, is not yet approved for use. Nevertheless, online forums reveal that people are purchasing unapproved versions of the drug, which are not intended for human consumption, ...
Oct 15, 2026
0
27
Excessive physical exercise affects more than just the muscles; it can also alter brain chemistry. A new study published in the journal Neuroscience reveals that exhaustive training without adequate rest alters the regulation ...
Nov 2, 2026
0
27
GLP-1 (glucagon-like peptide-1 receptor agonists) medications, currently popular for weight loss, may help prevent type 2 diabetes and lower the risk of heart attack and stroke more than the standard diabetes prevention medication ...
Nov 2, 2026
0
27
New research uncovers the potential benefits and risks of sodium-glucose cotransporter 2 (SGLT2) inhibitors for adults aged 80 years or older with chronic kidney disease (CKD). The findings will be presented at ASN Kidney ...
Oct 24, 2026
0
26
The biggest international study ever on risky play has found that children who have more opportunities for outdoor adventurous play tend to have better physical and mental health, as well as improved social and cognitive ...
Oct 26, 2026
0
26
